non-small-cell-lung-cancer

Documents about non-small-cell-lung-cancer

• Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer#184860ClinicalTrials.gov
• Circulating DNA in Surgically Treated NSCLC#184844ClinicalTrials.gov
• MRNA Neoantigen Vaccine in Non-Small Cell Lung Cancer#481793ClinicalTrials.gov
• Personalized DC Vaccine for Postoperative Cancer#141079ClinicalTrials.gov
• LIFE - Lung Cancer, Immunotherapy, Frailty, Effect#146440ClinicalTrials.gov
• Electro-Acupuncture in Lung cancER : EALER Study#435748ClinicalTrials.gov
• Prospective Epidemiological Study of Metastatic Non Small Cell Lung Cancer (NSCLC) in Latin America#806198ClinicalTrials.gov
• A Study of LY3023414 and Necitumumab in Squamous Lung Cancer#834857ClinicalTrials.gov
• A Study to Demonstrate the Benefit of a New Kind of Anti-cancer Treatment [PReferentially Expressed Antigen of MElanoma (PRAME) Immunotherapy] for Patients With Non-Small Cell Lung Cancer (NSCLC), After Removal of Their Tumor#451521ClinicalTrials.gov
• Amivantamab in advanced non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations: Real-world data from the Italian ATLAS Registry#254454IRIS
• Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases#804177ClinicalTrials.gov
• Early Switch Maintenance vs Delayed Second-line Nivolumab in Advanced Stage Squamous Non-small Cell Lung Cancer (NSCLC) Patients (EDEN Trial)#841192ClinicalTrials.gov
• Consolidation Conventional Radiotherapy + Stereotactic Body Radiotherapy at 3 Months After First-line Chemotherapy in Stage IV Oligometastatic Non-small Cell Lung Cancer#841850ClinicalTrials.gov
• Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer#238091ClinicalTrials.gov
• IMMUNO-LUNG : Identification of Biomarkers and Therapeutic Targets for Pulmonary Immunotherapy#343834ClinicalTrials.gov
• Nous-PEV: a Novel Immunotherapy for Lung Cancer and Melanoma#463705ClinicalTrials.gov
• Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer#460084ClinicalTrials.gov
• Safety and Efficacy of Neoantigen-Based Personalized Immunotherapy as Consolidation Therapy After Standard Adjuvant Treatment in Resectable Stage III Colorectal Cancer or Non-Small Cell Lung Cancer#683072ClinicalTrials.gov
• Immunotherapy With or Without SBRT in Patients With Stage IV Non-small Cell Lung Cancer#158236ClinicalTrials.gov
• Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases#283033ClinicalTrials.gov
• Vaccine-Based Immunotherapy Regimen For NSCLC and TNBC#230401ClinicalTrials.gov
• Deciphering the Impact of HER2 Alterations on Non-Small-Cell Lung Cancer: From Biological Mechanisms to Therapeutic Approaches#215401HAL (France)
• The significance of co-mutations in EGFR-mutated non-small cell lung cancer: Optimizing the efficacy of targeted therapies?#215411HAL (France)
• Fluorine-18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer#825138ClinicalTrials.gov
• Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy#195324ClinicalTrials.gov
• Study of Plasma NGS for Assessment, Characterization, Evaluation of Patients With ALK Resistance#226281ClinicalTrials.gov
• Detection of Minimal Residual Disease in Resectable Stage II-IIIB Non-small Cell Lung Cancer#474752ClinicalTrials.gov
• Relation Between Tumor-draining Lymph Nodes Metastasis Pattern and Non-small Cell Lung Cancer Neoadjuvant Immunotherapy Effectiveness#674899ClinicalTrials.gov
• Sunvozertinib (DZD9008) in Pretreated Lung Cancer Patients with EGFR Exon20 Insertion Mutation (WU-KONG6)#832602ClinicalTrials.gov
• Hydroxychloroquine Combined With Gemcitabine in the Treatment of Advanced Non-small Cell Lung Cancer#835150ClinicalTrials.gov
• Using Infrared Spectroscopy to Analyze Volatile Organic Compounds (VOCs) in the Breath of Patients With Lung Cancer#825297ClinicalTrials.gov
• Endostar/PD-1 Inhibitors Combined With PP for Advanced NSCLC#640554ClinicalTrials.gov
• Trial-specific Patient Decision Aid (tPDA) of the ImmunoSABR Phase 2#444859ClinicalTrials.gov
• Drug Concentration Monitoring of Pembrolizumab in Non-Small Cell Lung Cancer Patients#160351ClinicalTrials.gov
• L-TIL Plus Tislelizumab for PD1 Antibody Resistant aNSCLC#394764ClinicalTrials.gov
• Chemoradiotherapy With Surgery Followed by Consolidation Durvalumab#442078ClinicalTrials.gov
• Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma#303722ClinicalTrials.gov
• Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer#343849ClinicalTrials.gov
• Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical Trial#28299ClinicalTrials.gov
• Durvalumab after radiotherapy in patients with unresectable stage III non-small-cell lung cancer ineligible for chemotherapy: the DUART phase II nonrandomized controlled study#257451HAL (France)
• Antibody-Drug Conjugates Beyond HER2 in Non-Small Cell Lung Cancer (NSCLC): Mechanisms, Emerging Targets, and Future Directions#289054ODU Digital Commons
• A Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) With Acquired Resistance to Immunotherapy and High Yes-associated Protein (YAP) Expression#311115ClinicalTrials.gov
• Five-year outcomes with gefitinib induction and chemoradiotherapy in EGFR-mutant stage III non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study#368427OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer#812608ClinicalTrials.gov
• A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.#807674ClinicalTrials.gov
• Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes#366577ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)#806597ClinicalTrials.gov
• Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR Mutation#800422ClinicalTrials.gov
• Chemotherapy With or Without Immune Checkpoint Inhibitors for Lung Cancer#812371ClinicalTrials.gov
• Evaluate Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of AZD3759#836943ClinicalTrials.gov